Showing results (111-120 of 166) with videos related to
Sort By:
Pageof 17
Journal of Hypertension|November 1, 1992
Quality of life in hypertensives treated with atenolol or captopril: a double-blind crossover trialA J Palmer, A E Fletcher, P J Rudge, et al.Gynecologic Oncology|January 1, 2014
Inhibition of α4β1 integrin increases ovarian cancer response to carboplatinJennifer M Scalici, Christine Harrer, Anne Allen, et al.The Journal of Allergy and Clinical Immunology|December 7, 2007
Cigarette smoking and allergic sensitization: a 32-year population-based cohort studyRobert J Hancox, David Welch, Richie Poulton, et al.Journal of Toxicology and Environmental Health|August 30, 1996
Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered?J Savory, C Exley, W F Forbes, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1991
Anomalous gene expression in Alzheimer disease: cause or effectD R McLachlan, W J Lukiw, C Mizzen, et al.QJM : Monthly Journal of the Association of Physicians|September 29, 2011
High sensitivity troponin T provides useful prognostic information in non-acute chest painJ George, D Jack, G Mackle, et al.The European Respiratory Journal|October 3, 2002
Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationshipS L Jones, P Herbison, J O Cowan, et al.American Journal of Respiratory and Critical Care Medicine|September 11, 2001
The predictive value of exhaled nitric oxide measurements in assessing changes in asthma controlS L Jones, J Kittelson, J O Cowan, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|February 24, 2001
The influence of polymorphism at position 16 of the beta2-adrenoceptor on the development of tolerance to beta-agonistD R Taylor, R J Hancox, W McRae, et al.Cancer|August 1, 1982
Chronic lymphatic leukemia developing in a patient with multiple myeloma: immunologic demonstration of a clonally distinct second malignancyJ R Zalcberg, F N Cornell, H J Ireton, et al.Pageof 17